Name | APTEKA N4, OOO |
|---|
INN | 5029075167 |
|---|
KPP | 502901001 |
|---|
OGRN | 1045005503905 |
|---|
OKPO | 70474478 |
|---|
Address | 141033, Moskovskaya Oblast', g.o. Mytischi, g. Mytischi, ul. Sovetskaya, d. D.1A |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores | | All types of activities | | 68.20 | Additional activity | Renting and operating of own or leased land, buildings and dwellings |
Registration date | 23.03.2004 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram po gorodu Mytischi Moskovskoy oblasti |
|---|
|
APTEKA N4, OOO (Moscow Oblast; INN 5029075167) was registered on 23 Mar 2004. The company's authorized capital as of July 1, 2012 was 12500 rub. Type of ownership of APTEKA N4, OOO - Limited liability companies. Form of ownership of APTEKA N4, OOO - Private property. Principal activities of APTEKA N4, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2022
Net profit (RAS) of APTEKA N4, OOO dropped in 2022 by 31.27% to 3.79 million RUB from 5.51 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 9.99% to 156.43 million RUB from 142.21 million RUB over 2021; cost of goods sold grew by 12.90% to 124.96 million RUB from 110.68 million RUB; sales profit fell by 13.37% to 4.99 million RUB from 5.76 million RUB. 2021
Net profit (RAS) of APTEKA N4, OOO dropped in 2021 by 16.54% to 5.51 million RUB from 6.60 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period 1.61 times to 142.21 million RUB from 88.41 million RUB over 2020; cost of goods sold grew 1.61 times to 110.68 million RUB from 68.93 million RUB; sales profit fell by 28.06% to 5.76 million RUB from 8.01 million RUB. 2020
Net profit (RAS) of APTEKA N4, OOO grew over 2020 2.23 times to 6.60 million RUB from 2.96 million RUB over 2019, the company informed. Revenue increased in the accounting period 1.86 times to 88.41 million RUB from 47.61 million RUB over 2019; cost of goods sold grew 1.85 times to 68.93 million RUB from 37.19 million RUB; sales profit went up 2.70 times to 8.01 million RUB from 2.96 million RUB. 2019
Net profit (RAS) of APTEKA N4, OOO grew over 2019 by 27.78% to 2.96 million RUB from 2.32 million RUB over 2018, the company informed. Revenue increased in the accounting period by 20.74% to 47.61 million RUB from 39.43 million RUB over 2018; cost of goods sold grew by 19.17% to 37.19 million RUB from 31.21 million RUB; sales profit went up by 27.78% to 2.96 million RUB from 2.32 million RUB. 2017
Net profit (RAS) of APTEKA N4, OOO dropped in 2017 by 15.80% to 3.71 million RUB from 4.41 million RUB over the same period in 2016, the company informed. Revenue decreased in the accounting period by 7.69% to 34.96 million RUB from 37.87 million RUB in 2016; cost of goods sold decreased by 6.98% to 30.86 million RUB from 33.17 million RUB; sales profit fell by 12.68% to 4.10 million RUB from 4.69 million RUB. 2016
Net profit (RAS) of APTEKA N4, OOO dropped in 2016 by 10.67% to 4.41 million RUB from 4.93 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 4.91% to 37.87 million RUB from 39.82 million RUB in 2015; cost of goods sold decreased by 4.12% to 33.17 million RUB from 34.60 million RUB; sales profit fell by 10.16% to 4.69 million RUB from 5.22 million RUB. 2014
Net profit (RAS) of APTEKA N 4, OOO grew over 2014 by 23.95% to 3.83 million RUB from 3.09 million RUB over 2013, the company informed. Revenue increased in the accounting period by 16.48% to 36.10 million RUB from 30.99 million RUB over 2013; cost of goods sold grew by 15.69% to 31.97 million RUB from 27.63 million RUB; sales profit went up by 22.94% to 4.13 million RUB from 3.36 million RUB. 2013
Net profit (RAS) of APTEKA N 4, OOO dropped in 2013 by 3.53% to 3.09 million RUB from 3.20 million RUB over the same period in 2012, the company informed. Revenue remained in the accounting period at the same level and made up 30.99 million RUB compared to 31.13 million RUB 31.13 million RUB; cost of goods sold remained at the same level amounting to 24.04 million RUB compared to 24.15 million RUB; sales profit fell by 1.87% to 3.36 million RUB from 3.42 million RUB. 2012
Net profit (RAS) of APTEKA N 4, OOO grew over 2012 by 15.59% to 3.20 million RUB from 2.77 million RUB over 2011, the company informed. Revenue increased in the accounting period by 11.24% to 31.13 million RUB from 27.98 million RUB over 2011; cost of goods sold grew by 10.91% to 27.71 million RUB from 24.98 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|